Alpha-1-antitrypsin protease inhibitor SZ phenotype and liver cirrhosis

Appl Pathol. 1989;7(1):54-60.

Abstract

In the light of recent findings concerning the importance of intermediate alpha 1-antitrypsin deficiency in the development of chronic liver disease and of hepatocellular carcinoma, we report the case of a 56-year-old woman affected by cirrhosis with significant features of liver cell dysplasia associated with intermediate alpha 1-antitrypsin deficiency (protease inhibitor SZ phenotype). In our paper we emphasize the importance of a precocious diagnosis and identification of individuals carrying the Z allele, also heterozygous.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Liver Cirrhosis / genetics*
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis / prevention & control
  • Middle Aged
  • Phenotype
  • alpha 1-Antitrypsin / genetics
  • alpha 1-Antitrypsin Deficiency*

Substances

  • alpha 1-Antitrypsin